4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one

HCID 122182

Notizen Reaktionen

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

Teilstruktursuche Ähnliche Strukturen suchen

Grundinformationen

CAS: 93211-49-5
Standard-SMILES: COc1ccc2nc3cc(OC)c(=O)c(Br)c-3sc2c1
InChIKey: YADZEEVOBOJZRG-UHFFFAOYSA-N
Summenformel: C14H10BrNO3S
Durchschnittliche Molmasse: 352,2 g/mol
Monoisotopische Masse: 350,95647628

Überblick

structure given in first source

Namen und Bezeichner

Bevorzugter Name: 4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one
IUPAC: 4-bromo-2,7-dimethoxyphenothiazin-3-one

Namen und Synonyme

4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one93211-49-5L-651,3926163B74DJY3H-Phenothiazin-3-one, 4-bromo-2,7-dimethoxy-L 651.392DTXSID60239339RefChem:98045DTXCID30161830L-6513924-bromo-2,7-dimethoxyphenothiazin-3-oneL 651392

Weitere Namen anzeigen

UNII-6163B74DJYorb1702124SCHEMBL2987610YADZEEVOBOJZRG-UHFFFAOYSA-NGLXC-04252AKOS030548517CS-0066957T25589

Datenbank-Bezeichner

CAS: 93211-49-5
PubChem CID: 122182
DTXSID: DTXSID60239339
UNII: 6163B74DJY
Nikkaji: J325.337F

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP: 3,1
Polarare Oberfläche (TPSA): 73,2 Å²
H-Brücken-Donoren: 0
H-Brücken-Akzeptoren: 5
Frei drehbare Bindungen: 2
Schwere Atome: 20
Formalladung: 0
Komplexität: 541

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 2 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.